Given Imaging considers sale, other alternatives
Given Imaging Ltd.'s shares jumped sharply in after-hours trading Wednesday after the medical equipment company said that it is considering a sale.
The company said that it is reviewing a range of strategic options to enhance shareholder value, which includes early indications of interest from other parties that could lead to a sale or merger of the company.
The company, based in Israel, makes diagnostic products for gastrointestinal disorders including its PillCam capsules that patients swallow for internal examinations.
Given said that Barclays is assisting in its review process and an executive committee will oversee the effort.
Given Imaging shares rose $1.73, or 11.3 percent, to $17 in after-hours trading. In the regular session the stock added 30 cents to end at $15.27.